Search Legislation

The General Pharmaceutical Council (Amendment) Rules Order of Council 2022

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As made)

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

SCHEDULEThe General Pharmaceutical Council (Amendment) Rules 2022

The General Pharmaceutical Council makes these Rules in exercise of the powers conferred by articles 61(1), (2)(a) and (6)(b) and 66(1) of the Pharmacy Order 2010(1).

In accordance with article 66(3) of that Order the Pharmaceutical General Council has consulted such persons or organisations as it considered appropriate.

Citation and commencement

1.  These Rules may be cited as the General Pharmaceutical Council (Amendment) Rules 2022 and come into force on 6th October 2022.

Amendment of the General Pharmaceutical Council (Appeals Committee Rules) Order of Council 2010

2.—(1) The General Pharmaceutical Council (Appeals Committee) Rules 2010(2) are amended as follows.

(2) In rule 2 (interpretation)—

(a)after the definition of “appellant” insert—

attend” means—

(a)

to be physically present at a meeting or hearing, or,

(b)

to be present at a meeting or hearing by teleconference or video link;; and

(b)after the definition of “parties” insert—

present” includes being in a meeting or hearing by teleconference or video link and “presence” is to be construed accordingly;.

(3) After rule 2 insert—

Virtual meetings and hearings

2A.  At the discretion of the chair, meetings or hearings of the Committee arranged under these Rules may be conducted by teleconference or video link..

(4) In rule 6 (notice of hearing), for sub-paragraph (a), substitute—

(a)state—

(i)the date, time and venue of the hearing, or

(ii)when the hearing is to be conducted by teleconference or video link, the date and time of the hearing and instructions on how to access the hearing;.

(5) After rule 16(4) (attendance of the public at hearings), insert—

(5) Reference to a hearing under this rule includes hearings conducted by teleconference or video link..

Amendment to the General Pharmaceutical Council (Fitness to Practise and Disqualification etc Rules) Order of Council 2010

3.—(1) The General Pharmaceutical Council (Fitness to Practise and Disqualification etc) Rules 2010(3) are amended as follows.

(2) In rule 2 (interpretation)—

(a)after the definition of “applicant concerned” insert—

attend” means—

(a)

to be physically present at a meeting or hearing, or,

(b)

to be present at a meeting or hearing by teleconference or video link;; and

(b)after the definition of “prescribed fee” insert—

present” includes being present at a meeting or hearing by teleconference or video link, except in the phrase “present their case”, and “presence” is to be construed accordingly; and

(3) After rule 2 (interpretation), insert—

Virtual meetings and hearings

2A.  At the discretion of the chair, meetings and hearings of the Committee arranged under these rules may be conducted by teleconference or video link..

(4) In rule 16 (notices of hearing other than interim order hearings), for sub-paragraph 2(a), substitute—

(a)state—

(i)the date, time and venue of the hearing, or

(ii)when the hearing is to be conducted by teleconference or video link the date and time of the hearing and instructions on how to access the hearing;.

(5) In rule 17 (interim order notices and court referrals), for sub-paragraph 2(a), substitute—

(a)state—

(i)the date, time and venue of the hearing, or

(ii)when the hearing is to be conducted by teleconference or video link, the date and time of the hearing and instructions on how to access the hearing;.

(6) After rule 39(4) (attendance of the public at hearings), insert—

(5) Reference to a hearing under this rule includes hearings conducted by teleconference or video link..

Given under the common seal of the General Pharmaceutical Council this 12th day of May 2022.

Legal seal

Gisela Abbam

Chair of the Council

Duncan Rudkin

Chief Executive and Registrar

(1)

S.I. 2010/231, to which there are amendments not relevant to this Order.

(2)

Rules as contained in the Schedule to the General Pharmaceutical Council (Appeals Committee Rules) Order of Council 2010 (S.I. 2010/1614).

(3)

Rules as contained in the Schedule to the General Pharmaceutical Council (Fitness to Practise and Disqualification etc Rules) Order of Council 2010 (S.I. 2010/1615).

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

Policy Note

Executive Note sets out a brief statement of the purpose of a Scottish Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Scottish Statutory Instrument accessible to readers who are not legally qualified and accompany any Scottish Statutory Instrument or Draft Scottish Statutory Instrument laid before the Scottish Parliament from July 2005 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources